Riskpilot← Back to searchSign inGet full accessNeurologi Världen AB
ABActiveOrg 5590669783Sannarpsvägen 20 AHospital activities · NACE 8610Est. 20160 employees
Revenue 2025
SEK -5
-100% vs 2024
EBITDA margin
2962860.0%
-127% vs 2024
Equity ratio
41.0%
Financial strength
Net profit 2025
SEK -321K
-272% vs 2024
| Revenue | SEK -5 | -100% |
| EBITDA | SEK -148K | -127% |
| Net profit | SEK -321K | -272% |
| Total assets | SEK 4,1M | -14% |
| Equity | SEK 1,7M | -16% |
| Employees | 0 | — |
Legal name
Neurologi Världen AB
Org number
5590669783
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
17 juni 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Neurologikonsult, hyrläkareuppdrag.
Address
Sannarpsvägen 20 A
Email
alirashidmajid@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 156 | 1 703 | 1 685 | 1 637 | −0 |
| Staff expenses | — | −142 | −970 | −859 | −258 |
| EBITDA | 1 367 | 1 322 | 486 | 539 | −148 |
| Depreciation & amort. | −194 | −194 | −194 | −194 | −87 |
| EBIT | 1 173 | 1 128 | 292 | 345 | −235 |
| Net financials | −31 | −33 | −33 | −110 | −86 |
| Profit before tax | 1 143 | 1 095 | 259 | 235 | −321 |
| Tax | −261 | −225 | −54 | −49 | — |
| Net profit | 882 | 870 | 205 | 186 | −321 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 503 | 5 089 | 4 852 | 4 697 | 4 061 |
| Equity | 1 521 | 1 991 | 2 001 | 1 987 | 1 666 |
| Long-term debt | 3 299 | 2 420 | 2 338 | 2 291 | 2 283 |
| Short-term debt | 683 | 679 | 513 | 419 | 112 |
| Total debt | 3 982 | 3 099 | 2 851 | 2 710 | 2 395 |
EBITDA margin
-14814300.0%
This company
15.8%
Market median
-93761492% vs market
20212025
Equity ratio
41.0%
This company
38.2%
Market median
+7% vs market
20212025
Return on equity
-19.3%
This company
18.4%
Market median
-205% vs market
20212025
Net profit margin
-32111000.0%
This company
8.1%
Market median
-396432199% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-07-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HF Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
AR Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Neurologi Världen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Huda Faisal Abdul Karem | Deputy Chief Executive Officer | 0 companies |
| Ali Rashid Majid Alabdullah | Chief Executive Officer | 0 companies |